Daiwa Securities Group
FMTX

Daiwa Securities Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Daiwa Securities Group’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-162
Closed -$3K – 1443
2022
Q3 		$3K Hold
162
– – ﹤0.01% 1213
2022
Q2 		$1K Hold
162
– – ﹤0.01% 1343
2022
Q1 		$2K Hold
162
– – ﹤0.01% 1283
2021
Q4 		$2K Hold
162
– – ﹤0.01% 1319
2021
Q3 		$4K Buy
162
+73
+82% +$1.73K ﹤0.01% 1205
2021
Q2 		$2K Hold
89
– – ﹤0.01% 1167
2021
Q1 		$2K Buy
89
+12
+16% +$433 ﹤0.01% 1171
2020
Q4 		$3K Buy
+77
New +$3.35K ﹤0.01% 1101

Daiwa Securities Group's FMTX Position: Q4 2022 in Review

Daiwa Securities Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 162 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in FMTX in Q4 2020 and held it in 8 quarters. The position peaked at $4K in Q3 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Daiwa Securities Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 162 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Daiwa Securities Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Daiwa Securities Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $4K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.